You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gsk239512

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in United States (GSK239512, Placebo)

Completed
Has Results
  • Schizophrenia
  • GSK239512
  • Placebo
  • Garden Grove, California
  • +14 more
Oct 9, 2017

Multiple Sclerosis Trial in Randwick (GSK239512, ketoconazole)

Completed
  • Multiple Sclerosis
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Jul 24, 2017

Alzheimer's Disease Trial in Worldwide (GSK239512, Placebo)

Completed
  • Alzheimer's Disease
  • GSK239512
  • Placebo
  • Randwick, New South Wales, Australia
  • +7 more
Jul 5, 2017

Alzheimer's Disease Trial in Worldwide (GSK239512, Placebo)

Completed
  • Alzheimer's Disease
  • GSK239512
  • Placebo
  • Ruse, Bulgaria
  • +34 more
Apr 11, 2017

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GSK239512, Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • GSK239512
  • Placebo
  • Sofia, Bulgaria
  • +42 more
Aug 12, 2016

Mild Cognitive Impairment, Dementia Trial in Toronto (GSK239512)

Completed
  • Mild Cognitive Impairment
  • Dementia
  • GSK239512
  • Toronto, Ontario, Canada
    GSK Investigational Site
May 31, 2012